Three Opportunities for Solazyme Inc (SZYM) Investors

Page 2 of 2

Fast-forward to the end of 2016 and the company is planning on having 550,000 metric tons of operating capacity installed with partners, while 300,000-350,000 metric tons will belong to Solazyme. That will require a good amount of new capital and partner commitments, but it is pretty tremendous growth that is impossible to ignore. Management isn’t shy about its ambitions either. They believe the company can grow revenues from $44 million in 2012 to over $1 billion with their final production capacity in place.

Foolish bottom line

Solazyme offers some interesting opportunities for investors looking to get into the growth that lies ahead in the industrial biotechnology industry. It is developing a diverse product portfolio with international partners, has had no trouble raising money with shareholders in mind, and is growing out of its shoes. The story will take years to play out and there could very well be obstacles ahead, but this is as good as it gets in the industry right now. Will you be buying this disruptive innovator? Let me know in the comments section below.

The article 3 Opportunities for Solazyme Investors originally appeared on Fool.com and is written by Maxx Chatsko.

Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio, his CAPS page, or follow him on Twitter @BlacknGoldFool to keep up with his writing on energy, bioprocessing, and emerging technologies.The Motley Fool owns shares of Solazyme.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2